Apollo studies for PTSD are underway

Apollo studies for PTSD are underway

In over 70 real-world case studies with Apollo users who report a diagnosis of Post Traumatic Stress Disorder (PTSD) using Apollo, all have reported substantially reduced feelings of hypervigilance (anxiety/restlessness) and improved attention, mood, and calm within 2-3 minutes of use. These effects were reported to last 30-120 minutes after 5-10 minutes of use. All subjects also reported improved sleep and fewer nightmares and sleep disturbances.

Apollo users who report a PTSD diagnosis have reported that they voluntarily take fewer opioid narcotics, benzodiazepines, and sleeping aids while using Apollo. Users also report that they drink less alcohol and caffeinated beverages like coffee while using Apollo. Over 100 Apollo beta testers with self-reported chronic pain and trouble sleeping have reported similar results.

Apollo is currently being studied to relieve symptoms of PTSD in real-world volunteers and in a clinical trial collaboration with the University of Pittsburgh and The New School in New York City. For more information, visit: https://clinicaltrials.gov/ct2/show/NCT03529981